Dexcom (DXCM) Change in Acquisitions & Divestments (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $468.2 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $468.2 million, down 27.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 billion (down 15.73% YoY), and the FY2025 annual result was $2.2 billion, down 23.36% from the prior year.
• Change in Acquisitions & Divestments advanced to $468.2 million in Q1 2026 per DXCM's latest filing, from $409.6 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.1 billion in Q1 2024 and troughed at $241.8 million in Q1 2022.
• A 5-year average of $619.6 million and a median of $638.7 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments plunged 69.39% in 2022, then soared 188.5% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $740.0 million in 2022, then decreased by 2.84% to $719.0 million in 2023, then sank by 43.64% to $405.2 million in 2024, then climbed by 1.09% to $409.6 million in 2025, then rose by 14.31% to $468.2 million in 2026.
• Business Quant data shows DXCM's Change in Acquisitions & Divestments at $468.2 million in Q1 2026, $409.6 million in Q4 2025, and $466.2 million in Q3 2025.